With no economic relief in sight, industry, like all of us, is grappling with high—and new—costs.

The good, the bad, and the ugly about direct-to-consumer advertising.

Scientists are giving up on a preventive vaccine for AIDS, but there are lessons to be learned.

The FDA itself issues a cry for help. Is anybody listening?

Can an overload of patent applications lead to the US' demise as a scientific leader?

Fixing FDA lies in the hands of the government, but is the president-to-be paying attention?

Drug makers, drug inspectors, and drug consumers need to demand that new drugs be effective.

Thanks to the media, Nobel Laureates are underrated, undervalued, and simply uncool.

Courts are denying the terminally ill access to experimental drugs, leaving many with no options.